Abionyx Pharma SA (ABNX) Stock Price & News

Why is ABNX down 4.33%?

Dive Deeper

ABNX:EPA

Abionyx Pharma SA

€1.63

-4.33%

(-0.074) 1D

Oct 2, 10:27:52 AM GMT+2 · EUR

All symbols

	Symbol	Price	Change	% Change

Generating top insights for ABNX...

Open

€1.66

High

€1.66

Low

€1.62

Mkt. cap

71.47M

Avg. vol.

167.13K

Volume

106.99K

52-wk high

€5.21

52-wk low

€1.62

EPS

-€0.23

Shares outstanding

43.74M

No. of employees

Open

€1.66

High

€1.66

Low

€1.62

Mkt. cap

71.47M

Avg. vol.

167.13K

Volume

106.99K

52-wk high

€5.21

52-wk low

€1.62

EPS

-€0.23

Shares outstanding

43.74M

No. of employees

Related stocks

News stories

From web sources and news partners

TipRanks

2 hours ago

ABIONYX Pharma trims bond debt with share-backed repayment, keeps cash runway to 2028

Yahoo Finance

3 hours ago

ABIONYX Pharma Announces the Settlement of an Anticipated Amortization Payment in Accordance With the Terms of Its Bonds Financing Agreement

About Abionyx Pharma SA

CEOCyrille Tupin

Employees49

Founded2005

Headquarters-

SectorBiotechnology

Websiteabionyx.com

All values in EUR	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	1.06M	1.06M	972.00K	972.00K
Cost of goods sold	945.50K	945.50K	819.00K	819.00K
Cost of revenue	945.50K	945.50K	819.00K	819.00K
Research and development expenses	346.00K	346.00K	413.00K	413.00K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	938.00K	938.00K	1.35M	1.35M
Operating expense	1.28M	1.28M	1.76M	1.76M
Total operating expenses	2.22M	2.22M	2.58M	2.58M
Operating income	-1.16M	-1.16M	-1.60M	-1.60M
Other non operating income	11.00K	11.00K	-19.00K	-19.00K
EBT including unusual items	-1.15M	-1.15M	-1.62M	-1.62M
EBT excluding unusual items	-1.15M	-1.15M	-1.62M	-1.62M
Income tax expense	4.00K	4.00K	500.00	500.00
Effective tax rate	-0.35%	-0.35%	-0.03%	-0.03%
Other operating expenses	-5.00K	-5.00K	-5.00K	-5.00K
Net income	-1.15M	-1.15M	-1.62M	-1.62M
Net profit margin	-108.82%	-108.82%	-166.87%	-166.87%
Earnings per share	-	-	-	-
Interest and investment income	8.50K	8.50K	18.50K	18.50K
Interest expense	-26.50K	-26.50K	-16.00K	-16.00K
Net interest expenses	-18.00K	-18.00K	2.50K	2.50K
Depreciation and amortization charges	-	-	-	-
EBITDA	-1.13M	-1.13M	-1.58M	-1.58M
Gain or loss from assets sale	-	-	-	-

Ask anything